It leverages additional biochemical and immunohistochemical readouts from the same tissue samples, making it a unique and comprehensive data resource to understand the AD landscape of brain myeloid cells across tau progression [1, 14, 30, 41]. Here, MAPT is linked to Alzheimer disease.